With the analysis among 64,214 patents, we discovered top 464 key players by total patent application. F. Hoffmann-La Roche Ltd., Eli Lilly & Co., Boehringer Ingelheim International GmbH are dominant in this area. They take 6.97% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Indiana, United States
Patent: 1,618
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1,090
Basel-Stadt, Switzerland
Patent: 950
Hovedstaden, Denmark
Patent: 856
Hessen, Germany
Patent: 832
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 811
Antwerpen, Belgium
Patent: 803
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 788
New York, United States
Patent: 745
With the analysis among 957 patents, we discovered top 137 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Intarcia Therapeutics, Inc., Bigfoot Biomedical, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Intarcia Therapeutics, Inc.
California, United States
Patent: 59
California, United States
Patent: 48
Telangana, India
Patent: 39
New York, United States
Patent: 31
Kanagawa-ken, Japan
Patent: 27
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 25
ImmunoMet Therapeutics, Inc.
Texas, United States
Patent: 21
Massachusetts, United States
Patent: 21
Ohio, United States
Patent: 19
With the analysis among related 19,306 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Eli Lilly & Co., Novo Nordisk A/S, Janssen Pharmaceutica NV take 4.13% of patent filing during this period.
Indiana, United States
Patent: 463
Hovedstaden, Denmark
Patent: 188
Antwerpen, Belgium
Patent: 147
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 129
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 99
Nordrhein-Westfalen, Germany
Patent: 97
F. Hoffmann-La Roche Ltd.
With the analysis among related 19,306 patents in last 5 years, we discover 111 new entrants. Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd., Quantum Genomics SA, College de France are the most active new entrants in this area.
Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd.
Shanghai Shi, China
Patent: 47
ANTRIM COUNTY, United Kingdom
Patent: 31
New York, United States
Patent: 31
University of Connecticut
Connecticut, United States
Patent: 25
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 25
Catalyst Biosciences, Inc.
California, United States
Patent: 25
Henan Provincial Hospital
Henan Sheng, China
Patent: 23
With the analysis among 15,517 patents, we discovered top 308 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, China Pharmaceutical University, The Trustees of Columbia University in The City of New York are dominant in this area. They take 5.22% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 185
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 175
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 166
President & Fellows of Harvard College
Massachusetts, United States
Patent: 164
Council of Scientific & Industrial Research
Case Western Reserve University
Ohio, United States
Patent: 119
Zhejiang Sheng, China
Patent: 98
University of Southern California
California, United States
Patent: 92
Connecticut, United States
Patent: 92
Chinese Academy of Medical Scciences & Peking Union Medical College